Overcapacity in the Office Chair Market
There is indeed an overcapacity phenomenon in the office chair market, with specific manifestations and causes as follows:
1. Overall Industry Overcapacity and Vicious Cycle of Low-Price Competition
The domestic massage chair industry (including the office chair segment) has experienced frequent vicious low-price competition due to the expansion of production capacity far exceeding market demand. Some companies, in an attempt to seize market share, reduce costs by cutting corners, using inferior materials, or even producing counterfeit and shoddy products, further exacerbating market chaos. This competitive model not only compresses industry profit margins but also leads to misallocation of resources, making it difficult for high-quality production capacity to be released.
2. Regional Overcapacity Concentration and Mismatch of Testing Resources
Taking Langfang Bazhou as an example, as the largest metal and glass furniture industrial base in China, it has over 4,000 furniture and supporting enterprises, with an annual production capacity of 100 million units (sets), exporting to more than 130 countries and regions. However, the industrial cluster has long faced issues of 'difficult and expensive testing,' with some companies experiencing delays in export efficiency due to lagging test reports. This contradiction indicates that the structural imbalance between excessive regional production capacity concentration and insufficient testing resources indirectly leads to overcapacity.
3. Structural Contradiction: Homogenized Production and Disconnection from Demand Upgrades
Although the scale of China's office furniture industry has exceeded 200 billion yuan, market concentration is low, and regional and homogenized competition is severe. Companies generally focus on low-price orders, while health management needs (such as ergonomic support and environmental compliance) have not been fully met. For example, low-end office chairs (<236 yuan) account for 64.9% of sales volume but only contribute 21.8% to sales revenue; high-end products (>1335 yuan) account for 3.5% of sales volume but capture 34.2% of sales revenue. Profit distribution follows a 'dumbbell' pattern, with the proliferation of low-priced products further exacerbating overcapacity.
4. Solutions: Technological Upgrades and Resource Integration
Resolving overcapacity requires efforts from both the supply and demand sides:
- Technological Upgrades: Promote differentiated products such as ergonomic designs and eco-friendly materials to meet health management needs;
- Standard Strengthening: Eliminate inferior production capacity through environmental certifications and quality inspections;
- Resource Sharing: Establish shared testing platforms to alleviate regional testing resource shortages.
Overcapacity is the result of low-price competition, homogenized production, and insufficient testing resources in the industry, requiring structural reforms to achieve high-quality development.
